Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution.
SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries.
Company Details
- Employees
- 76
- Founded
- -
- Address
- Savanorių Pr., 178c,lithuania
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dropletgenomics.com
- Keywords
- Microfluidics, Biosciences, R&D, Semi–Permeable Capsules, Single‑Cell Analysis, High‑Throughput Screening, Research, Multi-Step Workflows, Droplet Generation, Droplet Manipulation, Single-Cell Analysis.
- HQ
- Vilnius, Lithuania
Atrandi Biosciences Questions
Atrandi Biosciences's website is dropletgenomics.com
Atrandi Biosciences's LinkedIn profile is https://lt.linkedin.com/company/atrandi
Atrandi Biosciences has
76 employees.
View email and phone details for 76
employees at Atrandi Biosciences.
Atrandi Biosciences's industry is
Biotechnology Research
Atrandi Biosciences's top competitors are
Cast Ai,
Biomatter,
Sanobiotec,
Caszyme,
Vugene,
Lithuaniabio,
Biok Lab,
Delta Biosciences,
Genie Biotech,
Northway Biotech.
Atrandi Biosciences's categories are Biotechnology Research
Atrandi Biosciences's founding year is 2016
